Comparison
1p35 2 Microdeletion Syndrome vs 11p15 4 Microduplication Syndrome C4749508
Clinical comparison between 1p35 2 Microdeletion Syndrome and 11p15 4 Microduplication Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
1p35 2 Microdeletion Syndrome
0-null
11p15 4 Microduplication Syndrome C4749508
0-null
Onset patterns differ
Severity
1p35 2 Microdeletion Syndrome
severe
11p15 4 Microduplication Syndrome C4749508
moderate
Different severity levels
Chronic
1p35 2 Microdeletion Syndrome
Chronic
11p15 4 Microduplication Syndrome C4749508
Chronic
Differing course
Communicable
1p35 2 Microdeletion Syndrome
No
11p15 4 Microduplication Syndrome C4749508
No
Different transmission
Body System
1p35 2 Microdeletion Syndrome
congenital
11p15 4 Microduplication Syndrome C4749508
congenital
Same/different system
Category
1p35 2 Microdeletion Syndrome
rare-disease
11p15 4 Microduplication Syndrome C4749508
genetic
Different category
Bottom line
1p35-2-microdeletion-syndrome-C5679992 and 11p15-4-microduplication-syndrome-C4749508 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1p35 2 Microdeletion Syndrome | 11p15 4 Microduplication Syndrome C4749508 | Discriminating power |
|---|---|---|---|
| Copy-number change | Loss of material at 1p35.2 is the defining concept. | Gain of material at 11p15.4 is the defining concept. | High |
| Developmental features | A specific phenotype is not established in the supplied data. | Varied developmental features are described, but no definitive pattern is given. | Low |
| Clinical severity label | Source axis labels severity as severe. | Source axis labels severity as moderate. | Moderate |
When to favor each condition
Choose 1p35 2 Microdeletion Syndrome when
Confirmed loss at 1p35.2
The chromosomal locus and deletion direction match the left concept.
High
Severe congenital presentation
Severity may support consideration, but phenotype alone does not establish the diagnosis.
Low
Family genetic counseling
A verified deletion can guide individualized assessment; recurrence risk is not established here.
Moderate
Choose 11p15 4 Microduplication Syndrome C4749508 when
Confirmed gain at 11p15.4
The locus and duplication direction match the right concept.
High
Varied developmental findings
This fits the supplied description but is not specific without genomic confirmation.
Low
Moderate congenital course
The source severity label may align, but clinical severity requires clinician interpretation.
Moderate
How key tests differ
| Test | 1p35 2 Microdeletion Syndrome | 11p15 4 Microduplication Syndrome C4749508 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show a deletion involving 1p35.2. | May show a duplication involving 11p15.4. | Locus and copy-number direction discriminate; laboratory confirmation is required. |
| Karyotype | May be normal if the change is submicroscopic. | May also be normal if the change is submicroscopic. | A normal karyotype does not exclude either concept. |
| Targeted confirmation test | Confirms loss when appropriately designed for 1p35.2. | Confirms gain when appropriately designed for 11p15.4. | Use only to verify a suspected region; exact thresholds are not supplied. |
Prognosis comparison
1p35 2 Microdeletion Syndrome
- Outcome
- Long-term outcome is not established; source severity is labeled severe.
- Factors
- Exact deletion content, associated findings, and supportive care may influence course.
11p15 4 Microduplication Syndrome C4749508
- Outcome
- Outcome is variable and not quantified; source severity is labeled moderate.
- Factors
- Duplication extent and individual developmental findings may influence course.
Time frame: Both are described as chronic congenital conditions; precise milestones are unavailable.
Genomic confirmation, clinical findings, and access to supportive care matter more than the label.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental difficulty | Possible, but specific complications are not established. Varied developmental features are described without a fixed complication list. Do not infer a particular deficit from the concept name alone. |
| Congenital anomalies | Not specified in the supplied source. Not specified beyond a congenital genetic disorder. Organ-system findings require individual clinical evaluation. |
| Medical complexity | Severe label suggests potentially greater complexity, not a measured outcome. Moderate label suggests variable complexity. These labels are source classifications, not prognostic proof. |
Patient education highlights
- HighDiagnosis versus result
A chromosomal finding needs clinical correlation and does not by itself define every symptom.
- HighIndividual assessment
Care should be tailored because reported features and severity can vary.
- MediumInheritance questions
Family implications require genetics review; recurrence risk is not established here.